Companies · Other Health Care

Planrise, Inc.

WELLESLEY · Other Health Care

Diligence memoA one-page analyst read on Planrise, Inc. — recommendation, valuation, rhythm, risks.
$305K
Total raised · real
2
Rounds
2.0×
Latest step-up
Top 86%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Planrise, Inc. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.89× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era.
  • Within the normal band (89% of peer median) for its niche.
At-risk
  • Last raise 4.0 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Planrise, Inc. is one of 5376 Other Health Care companies tracked from WELLESLEY. By capital raised it ranks in the long tail (ahead of 15% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
10
Investors (latest)
2019
Year incorporated
2022-07-18
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3M$2.5M$3.8M$5.0MPre-Seed · 2020-11-12 Raised $100K (real) Modeled valuation $2.6M (est)$100K$2.6MPre-Seed2020Pre-Seed · 2022-07-18 Raised $205K (real) Modeled valuation $2.3M (est)$205K$2.3MPre-Seed2022+$205KCumulative $305K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$100K · 2020
Pre-Seed extension$205K · 2022

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$2.3M
Base estimate est.
$128K
Conservative case
$13.9M
Upside case
$1.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $2.6M · 2020-11-122020Pre-Seed · modeled $2.3M · 2022-07-182022
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
4.0 yr
Elapsed time used
4.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$181K/yr
Capital velocity
5.6 yr
On record since
2020
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$305K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.6× of median
This company$205K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$2.3M
Sector median$22.1M

Raised more than 15% of sector peers (real $). Modeled value above 10% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #156 of 288.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Active Recovery TMS, LLC · Pre-Seed Raised $1.0M · modeled $14.1M (est)Imagen Walled Lake Support Services, LLC · Pre-Seed Raised $977K · modeled $12.9M (est)Pinnacle Integrated Medicine, Inc. · Pre-Seed Raised $2.3M · modeled $12.3M (est)Choix, Inc. · Pre-Seed Raised $1000K · modeled $12.2M (est)DataBiologics, Inc. · Pre-Seed Raised $815K · modeled $11.2M (est)DIAGGO, Inc. · Pre-Seed Raised $1.0M · modeled $11.1M (est)American Nitrile Intermediate Holdings, LLC · Pre-Seed Raised $1.8M · modeled $10.4M (est)2636696 Ontario Inc. · Pre-Seed Raised $1.3M · modeled $9.9M (est)Exo-Toe, Llc · Pre-Seed Raised $1.2M · modeled $9.6M (est)RoddyMedical Holdings, Inc. · Pre-Seed Raised $915K · modeled $9.6M (est)Phoeb-X, Inc. · Pre-Seed Raised $912K · modeled $9.5M (est)NeuroGlove, LLC · Pre-Seed Raised $1.0M · modeled $9.1M (est)Planrise, Inc. (this company) Raised $305K · modeled $2.3M (est)Planrise, Inc.
CompanyStageRaised · realValue · estvs peer med.
Active Recovery TMS, LLCPre-Seed$1.0M$14.1M5.51×
Imagen Walled Lake Support Services, LLCPre-Seed$977K$12.9M5.05×
Pinnacle Integrated Medicine, Inc.Pre-Seed$2.3M$12.3M4.81×
Choix, Inc.Pre-Seed$1000K$12.2M4.78×
DataBiologics, Inc.Pre-Seed$815K$11.2M4.37×
DIAGGO, Inc.Pre-Seed$1.0M$11.1M4.35×
American Nitrile Intermediate Holdings, LLCPre-Seed$1.8M$10.4M4.07×
2636696 Ontario Inc.Pre-Seed$1.3M$9.9M3.87×
Exo-Toe, LlcPre-Seed$1.2M$9.6M3.77×
RoddyMedical Holdings, Inc.Pre-Seed$915K$9.6M3.76×
Phoeb-X, Inc.Pre-Seed$912K$9.5M3.71×
NeuroGlove, LLCPre-Seed$1.0M$9.1M3.56×
Planrise, Inc. this companyPre-Seed$305K$2.3M0.89×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$100K2020-11-12$556K$2.6M90%
Pre-Seed$205K2022-07-18$1.1M$2.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$100K2020-11-12
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$205K2022-07-18
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 10 investors on this round.
Intelligence
2024 ~Q1
Modeled next raise · ~20mo cadence
$418K
Modeled next size est.range $272K$670K
2.0×
Last step-up
$181K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Hemant Shah5 other2020-11
Cheyenne Welker1 other2020-11
Reza Sanjar1 other2020-11
Roberto Tepichin1 other2020-11
Sivan Patel1 other2020-11
Registry & provenance

Planrise, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1788978
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Open Chair, LLCOther Health CarePre-Seed$200K$6.2Mnetwork1 shared operator · same sector · same stage
Arthroba, Inc.Other Health CarePre-Seed$300K$2.4Msame sector · same stage
Austin Center For Outpatient Surgery, L.P.Other Health CarePre-Seed$314K$2.5Msame sector · same stage
Naavacare LLCOther Health CarePre-Seed$330K$2.7Msame sector · same stage
Lapovations LLCOther Health CarePre-Seed$275K$2.1Msame sector · same stage
PHmHealth LLCOther Health CarePre-Seed$275K$3.1Msame sector · same stage
Cloud Dentistry, Inc.Software / TechSeed$10.3M$1.8Mnetwork3 shared operators
3DIO Inc.Other Health CarePre-Seed$349K$1.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
UpHealth, Inc.Other Health CareSeries A$34.7M86%
Algorics Inc.Other Health CareSeed$17.2M84%
Iris Plans, Inc.Other Health CareSeries A$75.7M84%
Intellihealth, Inc.Other Health CareSeries B$22.6M83%
Intellivisit Inc.Other Health CareSeed$17.1M83%
CardioWise, Inc.Other Health CareSeed$8.0M82%
1NHealth, Inc.Other Health CarePre-Seed$20.1M82%
CaredFor, Inc.Other Health CarePre-Seed$22.7M82%
Frequently asked
How much funding has Planrise, Inc. raised?
Planrise, Inc. has raised approximately $305K in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Planrise, Inc.'s estimated valuation?
Provath's modeled valuation for Planrise, Inc. is approximately $2.3M (modeled range $128K–$13.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Planrise, Inc. at?
Planrise, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Mon Jul 18.
What does Planrise, Inc. do and where is it based?
Planrise, Inc. operates in the Other Health Care sector, based in WELLESLEY.
Explore related

See where Planrise, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Planrise, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.